Trials / Completed
CompletedNCT05932303
A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants
A Phase 1, 3-arm, Open-label, Sequential Design Study to Investigate the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on Single-dose Pharmacokinetics of BMS-986278 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a study in healthy participants designed to assess the effect of multiple doses of itraconazole, gemfibrozil, or carbamazepine on the drug levels of a single-dose of BMS-986278.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986278 | Specified dose on specified days |
| DRUG | Itraconazole | Specified dose on specified days |
| DRUG | Gemfibrozil | Specified dose on specified days |
| DRUG | Carbamazepine | Specified dose on specified days |
Timeline
- Start date
- 2023-07-12
- Primary completion
- 2023-10-23
- Completion
- 2023-10-23
- First posted
- 2023-07-06
- Last updated
- 2023-10-30
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05932303. Inclusion in this directory is not an endorsement.